Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer
The evolution of targeted cancer theranostics has revolutionized personalized medicine by integrating diagnostic and therapeutic capabilities. Prostate-specific membrane antigen (PSMA) has emerged as a key theranostic target in the context of prostate cancer, paving the way for the clinical approval...
Gespeichert in:
| Veröffentlicht in: | ACS applied bio materials 2024-09, Vol.7 (9), p.5861-5884 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5884 |
|---|---|
| container_issue | 9 |
| container_start_page | 5861 |
| container_title | ACS applied bio materials |
| container_volume | 7 |
| creator | Solanki, Krishna Ahmed, Nazeer Srivastava, Nidhi Meher, Niranjan |
| description | The evolution of targeted cancer theranostics has revolutionized personalized medicine by integrating diagnostic and therapeutic capabilities. Prostate-specific membrane antigen (PSMA) has emerged as a key theranostic target in the context of prostate cancer, paving the way for the clinical approval of multiple drugs. However, the persistent challenge of off-target toxicity, which plagues both conventional and advanced treatment modalities such as targeted chemotherapy and radiotherapy, thus demands further innovation. Considering this critical issue, this review discusses the recent advances in the binary treatment techniques, i.e., phototherapies, that have the potential to circumvent the key concern of off-target toxicity associated with personalized chemotherapy and radiotherapy. Precisely, an up-to-date overview of the latest developments in the near-infrared (NIR)-based phototheranostic strategies for prostate cancer by targeting PSMA has been presented. Furthermore, we have discussed the associated particulars that require specific attention in enhancing the translational potential of phototheranostic techniques. |
| doi_str_mv | 10.1021/acsabm.4c00819 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3097852262</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3097852262</sourcerecordid><originalsourceid>FETCH-LOGICAL-a215t-1d3c127d5c2849ea91a79f5ccec1bdf4492f8388c01d71cc37b62b4ab75f4d043</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EolXpyogyIqQU23HieKwqPioVqKCdLedit6mapNjOwL_HKC1iYbobnvfR3YvQNcETgim5V-BUUU8YYJwTcYaGNOVZnDFKz__sAzR2bocxphgnJBeXaJAIIihn-RCtl7Z1Xnkdfxw0VKaC6EXXhVWNjqaNrza6iVfKbrTXZfQ6f4-W29a3fqsDEYIVuMi0NjpZoplqQNsrdGHU3unxcY7Q-vFhNXuOF29P89l0EStKUh-TMgFCeZkCzZnQShDFhUkBNJCiNIwJavIkzwGTkhOAhBcZLZgqeGpYiVkyQre992Dbz047L-vKgd7vw_lt52SCBc9TSjMa0EmPQjjVWW3kwVa1sl-SYPnTpuzblMc2Q-Dm6O6KWpe_-Km7ANz1QAjKXdvZJrz6n-0bwBl_ZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3097852262</pqid></control><display><type>article</type><title>Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer</title><source>MEDLINE</source><source>ACS Publications</source><creator>Solanki, Krishna ; Ahmed, Nazeer ; Srivastava, Nidhi ; Meher, Niranjan</creator><creatorcontrib>Solanki, Krishna ; Ahmed, Nazeer ; Srivastava, Nidhi ; Meher, Niranjan</creatorcontrib><description>The evolution of targeted cancer theranostics has revolutionized personalized medicine by integrating diagnostic and therapeutic capabilities. Prostate-specific membrane antigen (PSMA) has emerged as a key theranostic target in the context of prostate cancer, paving the way for the clinical approval of multiple drugs. However, the persistent challenge of off-target toxicity, which plagues both conventional and advanced treatment modalities such as targeted chemotherapy and radiotherapy, thus demands further innovation. Considering this critical issue, this review discusses the recent advances in the binary treatment techniques, i.e., phototherapies, that have the potential to circumvent the key concern of off-target toxicity associated with personalized chemotherapy and radiotherapy. Precisely, an up-to-date overview of the latest developments in the near-infrared (NIR)-based phototheranostic strategies for prostate cancer by targeting PSMA has been presented. Furthermore, we have discussed the associated particulars that require specific attention in enhancing the translational potential of phototheranostic techniques.</description><identifier>ISSN: 2576-6422</identifier><identifier>EISSN: 2576-6422</identifier><identifier>DOI: 10.1021/acsabm.4c00819</identifier><identifier>PMID: 39192748</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Antigens, Surface - metabolism ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biocompatible Materials - chemistry ; Biocompatible Materials - pharmacology ; Glutamate Carboxypeptidase II - metabolism ; Humans ; Infrared Rays ; Male ; Materials Testing ; Particle Size ; Phototherapy ; Prostatic Neoplasms - drug therapy ; Prostatic Neoplasms - pathology ; Theranostic Nanomedicine</subject><ispartof>ACS applied bio materials, 2024-09, Vol.7 (9), p.5861-5884</ispartof><rights>2024 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a215t-1d3c127d5c2849ea91a79f5ccec1bdf4492f8388c01d71cc37b62b4ab75f4d043</cites><orcidid>0000-0003-3558-3712</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsabm.4c00819$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsabm.4c00819$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,777,781,2752,27057,27905,27906,56719,56769</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39192748$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Solanki, Krishna</creatorcontrib><creatorcontrib>Ahmed, Nazeer</creatorcontrib><creatorcontrib>Srivastava, Nidhi</creatorcontrib><creatorcontrib>Meher, Niranjan</creatorcontrib><title>Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer</title><title>ACS applied bio materials</title><addtitle>ACS Appl. Bio Mater</addtitle><description>The evolution of targeted cancer theranostics has revolutionized personalized medicine by integrating diagnostic and therapeutic capabilities. Prostate-specific membrane antigen (PSMA) has emerged as a key theranostic target in the context of prostate cancer, paving the way for the clinical approval of multiple drugs. However, the persistent challenge of off-target toxicity, which plagues both conventional and advanced treatment modalities such as targeted chemotherapy and radiotherapy, thus demands further innovation. Considering this critical issue, this review discusses the recent advances in the binary treatment techniques, i.e., phototherapies, that have the potential to circumvent the key concern of off-target toxicity associated with personalized chemotherapy and radiotherapy. Precisely, an up-to-date overview of the latest developments in the near-infrared (NIR)-based phototheranostic strategies for prostate cancer by targeting PSMA has been presented. Furthermore, we have discussed the associated particulars that require specific attention in enhancing the translational potential of phototheranostic techniques.</description><subject>Animals</subject><subject>Antigens, Surface - metabolism</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biocompatible Materials - chemistry</subject><subject>Biocompatible Materials - pharmacology</subject><subject>Glutamate Carboxypeptidase II - metabolism</subject><subject>Humans</subject><subject>Infrared Rays</subject><subject>Male</subject><subject>Materials Testing</subject><subject>Particle Size</subject><subject>Phototherapy</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Theranostic Nanomedicine</subject><issn>2576-6422</issn><issn>2576-6422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAQhi0EolXpyogyIqQU23HieKwqPioVqKCdLedit6mapNjOwL_HKC1iYbobnvfR3YvQNcETgim5V-BUUU8YYJwTcYaGNOVZnDFKz__sAzR2bocxphgnJBeXaJAIIihn-RCtl7Z1Xnkdfxw0VKaC6EXXhVWNjqaNrza6iVfKbrTXZfQ6f4-W29a3fqsDEYIVuMi0NjpZoplqQNsrdGHU3unxcY7Q-vFhNXuOF29P89l0EStKUh-TMgFCeZkCzZnQShDFhUkBNJCiNIwJavIkzwGTkhOAhBcZLZgqeGpYiVkyQre992Dbz047L-vKgd7vw_lt52SCBc9TSjMa0EmPQjjVWW3kwVa1sl-SYPnTpuzblMc2Q-Dm6O6KWpe_-Km7ANz1QAjKXdvZJrz6n-0bwBl_ZQ</recordid><startdate>20240916</startdate><enddate>20240916</enddate><creator>Solanki, Krishna</creator><creator>Ahmed, Nazeer</creator><creator>Srivastava, Nidhi</creator><creator>Meher, Niranjan</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3558-3712</orcidid></search><sort><creationdate>20240916</creationdate><title>Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer</title><author>Solanki, Krishna ; Ahmed, Nazeer ; Srivastava, Nidhi ; Meher, Niranjan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a215t-1d3c127d5c2849ea91a79f5ccec1bdf4492f8388c01d71cc37b62b4ab75f4d043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Antigens, Surface - metabolism</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biocompatible Materials - chemistry</topic><topic>Biocompatible Materials - pharmacology</topic><topic>Glutamate Carboxypeptidase II - metabolism</topic><topic>Humans</topic><topic>Infrared Rays</topic><topic>Male</topic><topic>Materials Testing</topic><topic>Particle Size</topic><topic>Phototherapy</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Theranostic Nanomedicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Solanki, Krishna</creatorcontrib><creatorcontrib>Ahmed, Nazeer</creatorcontrib><creatorcontrib>Srivastava, Nidhi</creatorcontrib><creatorcontrib>Meher, Niranjan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ACS applied bio materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Solanki, Krishna</au><au>Ahmed, Nazeer</au><au>Srivastava, Nidhi</au><au>Meher, Niranjan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer</atitle><jtitle>ACS applied bio materials</jtitle><addtitle>ACS Appl. Bio Mater</addtitle><date>2024-09-16</date><risdate>2024</risdate><volume>7</volume><issue>9</issue><spage>5861</spage><epage>5884</epage><pages>5861-5884</pages><issn>2576-6422</issn><eissn>2576-6422</eissn><abstract>The evolution of targeted cancer theranostics has revolutionized personalized medicine by integrating diagnostic and therapeutic capabilities. Prostate-specific membrane antigen (PSMA) has emerged as a key theranostic target in the context of prostate cancer, paving the way for the clinical approval of multiple drugs. However, the persistent challenge of off-target toxicity, which plagues both conventional and advanced treatment modalities such as targeted chemotherapy and radiotherapy, thus demands further innovation. Considering this critical issue, this review discusses the recent advances in the binary treatment techniques, i.e., phototherapies, that have the potential to circumvent the key concern of off-target toxicity associated with personalized chemotherapy and radiotherapy. Precisely, an up-to-date overview of the latest developments in the near-infrared (NIR)-based phototheranostic strategies for prostate cancer by targeting PSMA has been presented. Furthermore, we have discussed the associated particulars that require specific attention in enhancing the translational potential of phototheranostic techniques.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>39192748</pmid><doi>10.1021/acsabm.4c00819</doi><tpages>24</tpages><orcidid>https://orcid.org/0000-0003-3558-3712</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2576-6422 |
| ispartof | ACS applied bio materials, 2024-09, Vol.7 (9), p.5861-5884 |
| issn | 2576-6422 2576-6422 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3097852262 |
| source | MEDLINE; ACS Publications |
| subjects | Animals Antigens, Surface - metabolism Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Biocompatible Materials - chemistry Biocompatible Materials - pharmacology Glutamate Carboxypeptidase II - metabolism Humans Infrared Rays Male Materials Testing Particle Size Phototherapy Prostatic Neoplasms - drug therapy Prostatic Neoplasms - pathology Theranostic Nanomedicine |
| title | Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A25%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prostate-Specific%20Membrane%20Antigen-Targeted%20NIR%20Phototheranostics%20for%20Prostate%20Cancer&rft.jtitle=ACS%20applied%20bio%20materials&rft.au=Solanki,%20Krishna&rft.date=2024-09-16&rft.volume=7&rft.issue=9&rft.spage=5861&rft.epage=5884&rft.pages=5861-5884&rft.issn=2576-6422&rft.eissn=2576-6422&rft_id=info:doi/10.1021/acsabm.4c00819&rft_dat=%3Cproquest_cross%3E3097852262%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3097852262&rft_id=info:pmid/39192748&rfr_iscdi=true |